Abstract
The antibody responses of 194 volunteers were studied for up to 3 years after primary immunization with one, two or three doses of human diploid cell rabies vaccine, administered either in 0.1 ml volumes intradermally (i.d.) or as 1.0 ml intramuscularly (i.m.). Sero-conversion occurred in 95% of subjects after the first injection and in 100% after the second. The highest titres and most durable antibody responses were induced by three injections of vaccine. Booster doses were administered either by the subcutaneous (s.c.) or i.d. route, after 6, 12 or 24 months to randomly grouped volunteers; these induced responses greater than or equal to 5.0 i.u. per ml in 95% of subjects. The responses were rapid and were neither influenced by the primary regimen nor by the timing and route of the booster dose. Antibody titres after i.d. immunization were only two-fold lower than those induced by the larger volume of vaccine. The findings suggest that the i.d. route is both effective and economic.
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ajjan N., Soulebot J. P., Triau R., Biron G. Intradermal immunization with rabies vaccine. Inactivated Wistar strain cultivated in human diploid cells. JAMA. 1980 Dec 5;244(22):2528–2531. doi: 10.1001/jama.244.22.2528. [DOI] [PubMed] [Google Scholar]
- Anderson L. J., Sikes R. K., Langkop C. W., Mann J. M., Smith J. S., Winkler W. G., Deitch M. W. Postexposure trial of a human diploid cell strain rabies vaccine. J Infect Dis. 1980 Aug;142(2):133–138. doi: 10.1093/infdis/142.2.133. [DOI] [PubMed] [Google Scholar]
- Aoki F. Y., Tyrrell D. A., Hill L. E. Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet. 1975 Mar 22;1(7908):660–662. doi: 10.1016/s0140-6736(75)91761-4. [DOI] [PubMed] [Google Scholar]
- Bahmanyar M., Fayaz A., Nour-Salehi S., Mohammadi M., Koprowski H. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA. 1976 Dec 13;236(24):2751–2754. [PubMed] [Google Scholar]
- Bøe E., Nyland H. Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis. 1980;12(3):231–232. doi: 10.3109/inf.1980.12.issue-3.12. [DOI] [PubMed] [Google Scholar]
- Cox J. H., Schneider L. G. Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine. J Clin Microbiol. 1976 Feb;3(2):96–101. doi: 10.1128/jcm.3.2.96-101.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuwert E. K., Marcus I., Höher P. G. Neutralizing and complement-fixing antibody responses in pre- and post-exposure vaccinees to a rabies vaccine produced in human diploid cells. J Biol Stand. 1976;4(4):249–262. doi: 10.1016/s0092-1157(76)80010-8. [DOI] [PubMed] [Google Scholar]
- Landolt A. M., Zachmann M. The Irish giant: new observations concerning the nature of his ailment. Lancet. 1980 Jun 14;1(8181):1311–1312. doi: 10.1016/s0140-6736(80)91774-2. [DOI] [PubMed] [Google Scholar]
- Lorenz R. J., Bögel K. Laboratory techniques in rabies: methods of calculation. Monogr Ser World Health Organ. 1973;(23):321–335. [PubMed] [Google Scholar]
- Miller A., Nathanson N. Rabies: recent advances in pathogenesis and control. Ann Neurol. 1977 Dec;2(6):511–519. doi: 10.1002/ana.410020611. [DOI] [PubMed] [Google Scholar]
- Nicholson K. G., Cole P. J., Turner G. S., Harrison P. Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon. J Infect Dis. 1979 Aug;140(2):176–182. doi: 10.1093/infdis/140.2.176. [DOI] [PubMed] [Google Scholar]
- Nicholson K. G., Prestage H. Enzyme-linked immunosorbent assay: a rapid reproducible test for the measurement of rabies antibody. J Med Virol. 1982;9(1):43–49. doi: 10.1002/jmv.1890090107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicholson K. G., Turner G. S., Aoki F. Y. Immunization with a human diploid cell strain of rabies virus vaccine: two-year results. J Infect Dis. 1978 Jun;137(6):783–788. doi: 10.1093/infdis/137.6.783. [DOI] [PubMed] [Google Scholar]
- Nicholson K. G., Turner G. S. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man. Dev Biol Stand. 1978;40:115–120. [PubMed] [Google Scholar]
- Plotkin S. A., Wiktor T. Rabies vaccination. Annu Rev Med. 1978;29:583–591. doi: 10.1146/annurev.me.29.020178.003055. [DOI] [PubMed] [Google Scholar]
- Rosanoff E., Tint H. Responses to human diploid cell rabies vaccine: neutralizing antibody responses of vaccinees receiving booster doses of human diploid cell rabies vaccine. Am J Epidemiol. 1979 Sep;110(3):322–327. doi: 10.1093/oxfordjournals.aje.a112817. [DOI] [PubMed] [Google Scholar]
- Simona R., Keller H., Spengler G., Gerber H., Weiss M., Steck F. Revakzination gegen Lyssa beim Menschen: Wirksamkeit verschiedener Boosterschemata. Schweiz Med Wochenschr. 1979 Nov 17;109(44):1702–1708. [PubMed] [Google Scholar]
- Turner G. S., Aoki F. Y., Nicholson K. G., Tyrrell D. A., Hill L. E. Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses. Lancet. 1976 Jun 26;1(7974):1379–1381. doi: 10.1016/s0140-6736(76)93028-2. [DOI] [PubMed] [Google Scholar]
- WIKTOR T. J., KOPROWSKI H. SUCCESSFUL IMMUNIZATION OF PRIMATES WITH RABIES VACCINE PREPARED IN HUMAN DIPLOID CELL STRAIN WI-38. Proc Soc Exp Biol Med. 1965 Apr;118:1069–1073. doi: 10.3181/00379727-118-30048. [DOI] [PubMed] [Google Scholar]
